Corbenic Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $6K | Hold |
37
| – | – | ﹤0.01% | 145 |
|
|
2022
Q1 | $6K | Hold |
37
| – | – | ﹤0.01% | 169 |
|
|
2021
Q4 | $5K | Sell |
37
-155
| -81% | -$20.9K | ﹤0.01% | 205 |
|
|
2021
Q3 | $21K | Buy |
192
+1
| +0.5% | +$109 | 0.01% | 116 |
|
|
2021
Q2 | $21K | Buy |
191
+1
| +0.5% | +$110 | 0.01% | 123 |
|
|
2021
Q1 | $21K | Buy |
190
+104
| +121% | +$11.5K | 0.01% | 121 |
|
|
2020
Q4 | $9K | Hold |
86
| – | – | ﹤0.01% | 130 |
|
|
2020
Q3 | $8K | Hold |
86
| – | – | ﹤0.01% | 113 |
|
|
2020
Q2 | $8K | Buy |
+86
| New | +$8K | ﹤0.01% | 106 |
|
|
2017
Q4 | $15K | Hold |
160
| – | – | 0.02% | 113 |
|
|
2017
Q3 | $14K | Buy |
+160
| New | +$14K | 0.02% | 121 |
|
|
2017
Q1 | – | Sell |
-153
| Closed | -$10K | – | 199 |
|
|
2016
Q4 | $10K | Hold |
153
| – | – | 0.01% | 133 |
|
|
2016
Q3 | $10K | Buy |
153
+28
| +22% | +$1.83K | 0.01% | 126 |
|
|
2016
Q2 | $8K | Buy |
+125
| New | +$8K | 0.01% | 133 |
|